PNC Financial Services Group’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-8
Closed -$141 4792
2024
Q1
$141 Buy
8
+3
+60% +$53 ﹤0.01% 4631
2023
Q4
$69 Buy
+5
New +$69 ﹤0.01% 4539